A detailed history of Portland Investment Counsel Inc. transactions in Isoray, Inc. stock. As of the latest transaction made, Portland Investment Counsel Inc. holds 70,001 shares of ISR stock, worth $48,300. This represents 0.02% of its overall portfolio holdings.

Number of Shares
70,001
Previous 70,001 -0.0%
Holding current value
$48,300
Previous $48,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
N/A
-272,549 Reduced 79.56%
70,001 $48,000
Q1 2024

May 14, 2024

BUY
N/A
200,000 Added 140.3%
342,550 $408,000
Q4 2023

Feb 14, 2024

BUY
N/A
142,550 New
142,550 $57,000
Q2 2023

Aug 14, 2023

BUY
$0.0 - $0.69 $0 - $713,529
1,034,100 New
1,034,100 $683,000

Others Institutions Holding ISR

# of Institutions
2
Shares Held
145K
Call Options Held
0
Put Options Held
0

About Isoray, Inc.


  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Portland Investment Counsel Inc. Portfolio

Follow Portland Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portland Investment Counsel Inc. with notifications on news.